x NoneEntity Type
0001633932
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 ESSA Pharma Inc.
Jurisdiction of Incorporation/OrganizationBRITISH COLUMBIA, CANADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 ESSA Pharma Inc. 
Street Address 1Street Address 2
 Suite 720, 999 West Broadway 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 Vancouver BRITISH COLUMBIA, CANADA V5Z 1K5 (778) 331-0962 



3. Related Persons
Last NameFirst NameMiddle Name
ParkinsonDavid
Street Address 1Street Address 2
820 Anderson Lane
CityState/Province/CountryZIP/Postal Code
SebastopolCALIFORNIA94872
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
VirsikPeter
Street Address 1Street Address 2
131 Escanyo Way
CityState/Province/CountryZIP/Postal Code
Portola ValleyCALIFORNIA94028
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
WoodDavid
Street Address 1Street Address 2
3516 West 33rd Avenue
CityState/Province/CountryZIP/Postal Code
VancouverBRITISH COLUMBIA, CANADAV6N 1H4
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
GlickmanRichard
Street Address 1Street Address 2
7764 West Saanich Road
CityState/Province/CountryZIP/Postal Code
Brentwood BayBRITISH COLUMBIA, CANADAV8M 1R7
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
SollisGary
Street Address 1Street Address 2
4218 Rockridge Road
CityState/Province/CountryZIP/Postal Code
West VancouverBRITISH COLUMBIA, CANADAV7W 1A4
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
BergerFranklin
Street Address 1Street Address 2
15th Floor, 257 Park Avenue South
CityState/Province/CountryZIP/Postal Code
New YorkNEW YORK10010
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RequadtScott
Street Address 1Street Address 2
15 Lewis Path
CityState/Province/CountryZIP/Postal Code
WaylandMASSACHUSETTS01778
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
MartinJohnAlex
Street Address 1Street Address 2
12 Penns Trail
CityState/Province/CountryZIP/Postal Code
NewtownPENNSYLVANIA18940
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
StampacchiaOtello
Street Address 1Street Address 2
888 Boylston St. Suite 1111
CityState/Province/CountryZIP/Postal Code
BostonMASSACHUSETTS02119
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ThorellAnnMarella
Street Address 1Street Address 2
267 Great Valley Parkway
CityState/Province/CountryZIP/Postal Code
MalvernPENNSYLVANIA19355
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ZweifachSandy
Street Address 1Street Address 2
130 Santa Road Ave.
CityState/Province/CountryZIP/Postal Code
SausalitoCALIFORNIA94965
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
x No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) o Rule 506(b)
o Rule 504 (b)(1)(ii) x Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2019-08-23 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Oppenheimer & Co. Inc. 249
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 85 Broad Street  
City State/Province/CountryZIP/Postal Code
 New York NEW YORK 10004
State(s) of Solicitation x All States o Foreign/Non-US
 

RecipientRecipient CRD Number x None
 Bloom Burton & Co.  
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 Suite 300, 65 Front Street East  
City State/Province/CountryZIP/Postal Code
 Toronto ONTARIO, CANADA M5E 1B5
State(s) of Solicitation o All States x Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 36000000 USD o Indefinite
Total Amount Sold $ 36000000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 14


15. Sales Commissions & Finders' Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 2108785 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ESSA Pharma Charts.
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ESSA Pharma Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EPIX Message Board. Create One! See More Posts on EPIX Message Board See More Message Board Posts

Essa Pharma Inc. News

Loading Messages....

More Essa Pharma Inc. News Articles